Dabigatran Etexilate

7 API suppliersSmall Molecule

Overview

Dabigatran Etexilate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL539697).

API suppliers (7)

Suppliers of Dabigatran Etexilate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India5

Country recorded for 5 of 7 suppliers.

4 of 7 hold a GMP certificate on record in the EU or UK registers

Patent & exclusivity (US)

Per the FDA Orange Book (32 approved US products), the latest listed US patent on Dabigatran Etexilate expires 20 Jul 2031. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name
ethyl 3-[[2-[[4-(N'-hexoxycarbonylcarbamimidoyl)anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate
Canonical SMILES
CCCCCCOC(=O)N=C(C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)N
InChIKey
KSGXQBZTULBEEQ-UHFFFAOYSA-N
Verified Supplier Partner

Do you supply Dabigatran Etexilate? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.